EN
登录

特朗普建议父母分开接种疫苗,推迟到12岁再注射乙肝疫苗:“这是基于我的感觉”

Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What:Feel'

benzinga 等信源发布 2025-09-22 22:32

可切换为仅中文


President

总统

Donald Trump

唐纳德·特朗普

on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain immunizations and delay certain others, in sharp contradiction to current medical recommendations.

周一提供了关于儿童疫苗接种时间表的建议,鼓励父母分开某些免疫接种并推迟其他一些接种,这与当前的医疗建议严重矛盾。

Advises Parents To Split Vaccines

建议父母分开接种疫苗

During a White House event that made unproven connections between acetaminophen, vaccines and autism, Trump said, “We want no mercury in the vaccine. We want no aluminum in the vaccine,” while adding that the MMR vaccine, or the measles, mumps and rubella vaccine, “should be taken separately,” according to a .

在白宫一场将对乙酰氨基酚、疫苗和自闭症之间建立未经证实的联系的活动中,特朗普表示:“我们希望疫苗中不含汞。我们希望疫苗中不含铝,”他补充说,根据一份报告,MMR疫苗,即麻疹、腮腺炎和风疹疫苗,“应该分开接种”。

report

报告

by The Hill.

由《The Hill》发布。

“This is based on what I feel,” he said, adding that “when you mix them, there could be a problem,” while highlighting that there were no downsides to taking them separately.

“这是基于我的感受,”他补充说,“当你混合使用它们时,可能会有问题,”同时他也强调分别使用它们没有任何负面影响。

See Also:

另请参阅:

Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax

Moderna报告称,更新版Spikevax抗体增加了8倍。

Trump also suggested that children should not receive the hepatitis B vaccine until the age of 12, citing the virus's sexual transmission routes. “Hepatitis B is sexually transmitted. There's no reason to give a baby almost just born hepatitis B,” he said. “I would say wait till the baby is 12 years old.”.

特朗普还建议儿童在12岁之前不应接种乙型肝炎疫苗,理由是该病毒通过性传播。“乙型肝炎是通过性传播的。没有理由给一个刚出生的婴儿接种乙型肝炎疫苗,”他说,“我认为应该等到孩子12岁。”

Medical experts have, however, warned that delaying the vaccines puts newborns at risk, noting that pregnant mothers with Hepatitis B can transmit it to their babies.

然而,医学专家警告说,推迟接种疫苗会使新生儿面临风险,并指出患有乙型肝炎的孕妇可以将其传染给婴儿。

When Trump was asked if it was appropriate to offer such guidance based on his personal views, he replied, saying that it was “absolutely appropriate.”

当被问及是否应该根据他的个人观点提供这样的指导时,特朗普回答说这“绝对合适”。

Trump said that these statements come directly from him, and not from the doctors. “I'm making these statements from me,” he said.

特朗普表示,这些声明直接来自他本人,而不是医生。“这些声明是我自己做的,”他说。

WHO Guidelines Contradict Trump’s Statements

世界卫生组织指南与特朗普的声明相矛盾

According to World Health Organization guidelines, all infants should receive a birth dose of the hepatitis B vaccine “as soon as possible after birth, preferably within 24 hours.”

根据世界卫生组织指南,所有婴儿应在出生后“尽快,最好在24小时内”接种乙肝疫苗的出生剂量。

This early dose is considered the most effective measure to prevent mother-to-child transmission of the virus, which poses the highest risk of chronic infection when acquired at birth.

这一早期剂量被认为是预防病毒母婴传播的最有效措施,出生时感染该病毒导致慢性感染的风险最高。

The WHO also endorses the use of combined MMR or MMRV formulations as part of standard immunization programs. WHO emphasizes that combination vaccines are both safe and effective, and explicitly states there is no increased risk from administering multiple vaccines during a single visit.

世界卫生组织还支持将麻疹-腮腺炎-风疹(MMR)或麻疹-腮腺炎-风疹-水痘(MMRV)联合疫苗作为标准免疫计划的一部分。世卫组织强调,联合疫苗既安全又有效,并明确表示在一次接种中同时接种多种疫苗不会增加风险。

Vaccine Schedule Faces Disruption

疫苗接种计划面临中断

Last week, the

上周,

Centers for Disease Control and Prevention’s Advisory Committee

疾病预防控制中心咨询委员会

on Immunization Practices

免疫实践

voted 8-3 in favor

投票结果为8比3赞成

of delaying the administration of the MMRV vaccine to children below the age of 4.

推迟给4岁以下儿童接种MMRV疫苗。

This comes from a newly constituted panel, with members “hand-picked” by the Health and Human Services secretary

这个新组成的小组成员是由卫生与公众服务部部长“精心挑选”的。

Robert F. Kennedy Jr.

罗伯特·F·肯尼迪 Jr.

, comprising several vaccine skeptics.

,包括几名疫苗怀疑论者。

Vaccine stocks have been hit hard by the Trump administration’s policies on immunization, with several leading biotech and pharmaceutical companies with exposure to the segment seeing steep year-to-date pullbacks.

疫苗类股票受到特朗普政府免疫政策的沉重打击,一些涉足该领域的领先生物技术和制药公司今年迄今出现了大幅回落。

The two leading manufacturers of MMRV vaccines in the U.S.

美国两家主要的MMRV疫苗制造商

are

Merck & Co.

默克公司

,

Inc.

公司

MRK

默克公司

and

GSK plc

葛兰素史克公司

GSK

葛兰素史克

, which may

,这可能

experience a decline in volumes as a result of these changes. The two pharmaceutical giants, alongside

由于这些变化,辉瑞和诺华这两家制药巨头的销量可能会下降。

Dynavax Technologies Corp.

Dynavax技术公司

DVAX

DVAX

, are also the top suppliers of the Hepatitis B vaccine in the U.S.

,也是美国乙肝疫苗的主要供应商。

Pfizer Inc.

辉瑞公司

PFE

辉瑞公司

,

Moderna Inc.

莫德纳公司

MRNA

信使核糖核酸

and

Novavax Inc.

诺瓦瓦克斯医药公司

NVAX

诺瓦瓦克斯医药

have witnessed pullbacks this past year, owing to the administration’s evolving COVID-19 vaccine policies.

由于政府不断演变的新冠疫苗政策,过去一年已经见证了回调。

Stocks

股票

Year-To-Date Performance

年初至今的表现

Pfizer Inc.

辉瑞公司

PFE

辉瑞公司

-9.66%

-9.66%

Moderna Inc.

莫德纳公司

MRNA

信使核糖核酸

-36.76%

-36.76%

Novavax Inc.

诺瓦瓦克斯医药公司

NVAX

诺瓦瓦克斯医药

+3.50%

+3.50%

Merck & Co., Inc.

默克公司

MRK

默克公司

-18.93%

-18.93%

GSK plc

葛兰素史克公司

GSK

葛兰素史克

+20.50%

+20.50%

Dynavax Technologies Corp.

Dynavax技术公司

DVAX

DVAX

-24.88%

-24.88%

Photo Courtesy: Joey Sussman on Shutterstock.com

照片来源:Joey Sussman 在 Shutterstock.com 提供

Loading...

加载中...

Loading...

加载中...

Read More:

阅读更多:

Metsera Stock Surges Over 60% In Monday Pre-Market As Pfizer Reportedly Nears Acquisition Deal: PFE Stock Up 1.5%

据报道,辉瑞即将达成收购协议,Metsera股票在周一盘前交易中飙升超过60%:PFE股票上涨1.5%。

DVAX

DVAX

Dynavax Technologies Corp

Dynavax技术公司

$9.69

9.69美元

-

-

%

%

Overview

概述

GSK

葛兰素史克

GSK PLC

葛兰素史克公司

$41.75

41.75美元

2.66

2.66

%

%

MRK

默克公司

Merck & Co Inc

默克公司

$80.65

80.65美元

-1.06

-1.06

%

%

MRNA

信使核糖核酸

Moderna Inc

莫德纳公司

$26.64

26.64美元

5.55

5.55

%

%

NVAX

诺瓦克斯医药

Novavax Inc

诺瓦瓦克斯医药公司

$8.88

8.88美元

1.95

1.95

%

%

PFE

辉瑞公司

Pfizer Inc

辉瑞公司

$24.17

24.17美元

0.58

0.58

%

%

Market News and Data brought to you by Benzinga APIs

由Benzinga API为您提供的市场新闻和数据

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

© 2025 Benzinga.com. Benzinga不提供投资建议。保留所有权利。